Reduction of blood cofilin-1 in cancer patients treated with radiotherapy

Meng-Hsiu Wu; Jyh-Der Leu; Yi-Jang Lee; Meng-Hsiu Wu; Jyh-Der Leu; Yi-Jang Lee

doi:10.3934/medsci.2022002

AIMS Medical Science

2022, Volume 9, Issue 1: 5-8. doi: 10.3934/medsci.2022002

Previous Article Next Article

Letter

Reduction of blood cofilin-1 in cancer patients treated with radiotherapy

1.
Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei 112, Taiwan
2.
Department of Radiation Oncology, Taipei City Hospital, RenAi Branch, Taipei 110, Taiwan
3.
Institue of Neuroscience, National Cheng Chi University, Taipei 116, Taiwan
4.
Cancer Progression Research Center, National Yang Ming Chiao Tung University, Taipei 112, Taiwan

Received: 01 September 2021 Revised: 09 January 2022 Accepted: 09 January 2022 Published: 11 January 2022

Citation: Meng-Hsiu Wu, Jyh-Der Leu, Yi-Jang Lee. Reduction of blood cofilin-1 in cancer patients treated with radiotherapy[J]. AIMS Medical Science, 2022, 9(1): 5-8. doi: 10.3934/medsci.2022002

Related Papers:

Acknowledgments

This study was supported by Taipei City Hospital (TPCH-106-011), and a grant from Ministry of Science and Technology of Taiwan (109-2314-B-010-021-MY3). We thank the administrative assistance from Ms. Ya-Huai Wang. The publication related fees, if any, was supported by the Ministry of Science and Technology of Taiwan (109-2314-B-010-021-MY3).

Conflict of interest

The authors declare that there are no conflicts of interest.

References

[1]	Satoh M, Takano S, Sogawa K, et al. (2017) Immune-complex level of cofilin-1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer. Cancer Sci 108: 795-803. https://doi.org/10.1111/cas.13181. doi: 10.1111/cas.13181
[2]	Zheng Y, Fang Y, Li S, et al. (2013) Detection of plasma cofilin protein for diagnosis of lung cancer. J Southern Med Univ 33: 1551-1553. (Article in Chinese).
[3]	Huang ZN, Chen Q Y, Zheng CH, et al. (2018) Are the indications for postoperative radiotherapy in the NCCN guidelines for patients with gastric adenocarcinoma too broad? A study based on the SEER database. BMC Cancer 18: 1-9. https://doi.org/10.1186/s12885-018-4957-6. doi: 10.1186/s12885-017-3892-2

Reader Comments

Your name:*

Email:*
© 2022 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)